Antinociceptive and anti-inflammatory effects of novel dietary protein hydrolysate produced from whey by proteases of Cynara cardunculus

International Dairy Journal

Volumn 32, Issue 2, 2013, Pages 156-162

  Tavares, T G ^a,b   Spindola, H ^c   Longato, G ^c   Pintado, M E ^a   Carvalho, J E ^c   Malcata, F X ^b,d  

^a UNIVERSIDADE CATÓLICA PORTUGUESA   (Portugal)

^b INSTITUTO DE TECNOLOGIA QUÍMICA E BIOLÓGICA   (Portugal)

^c UNIVERSITY OF CAMPINAS   (Brazil)

^d UNIVERSITY OF PORTO   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI-INFLAMMATORIES; ANTI-INFLAMMATORY EFFECTS; ANTINOCICEPTIVE; ANTINOCICEPTIVE EFFECT; CYNARA CARDUNCULUS; DEXAMETHASONES; DIETARY PROTEINS; STATISTICALLY SIGNIFICANT DIFFERENCE;

HYDROLYSIS; PLANTS (BOTANY);

TESTING;

EID: 84879464854     PISSN: 09586946     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.idairyj.2013.05.010     Document Type: Article

References (56)

1. Abbott F.V., Franklin K.B.J., Westbrook R.F. The formalin test: scoring properties of the first and second phases of the pain response in rats. Pain 1995, 60:91-102.
2. Anderson G.D., Hauser S.D., McGarity K.L., Bremer M.E., Isakson P.C., Gregory S.A. Selective inhibition of cyclooxygenase (COX)-2 reverses inflammation and expression of COX-2 and interleukin 6 in rat adjuvant arthritis. Journal of Clinical Investigation 1996, 97:2672-2679.
3. Barros R.M., Malcata F.X. Molecular characterization of peptides released from β-lactoglobulin and α-lactalbumin via cardosins A and B. Journal of Dairy Science 2006, 89:483-494.
4. Brock J. Lactoferrin: a multifunctional immunoregulatory protein?. Immunology Today 1995, 16:417-419.
5. Carr D.B., Goudas L.C. Acute pain. Lancet 1999, 353:2051-2058.
6. Cervero F., Laird J.M. Visceral pain. Lancet 1999, 353:2145-2148.
7. Daher J.B., Tonussi C.R. Aspinal mechanism for the peripheral anti-inflammatory action of indomethacin. Brain Research 2003, 962:207-212.
8. Elmer G.I., Pieper J.O., Negus S.S., Woods J.H. Genetic variance in nociception and its relationship to the potency of morphine-induced analgesia in thermal and chemical tests. Pain 1998, 75:129-140.
9. Ferreira S.H., Nakamura M. III - Prostaglandin hyperalgesia: relevance of the peripheral effect for the analgesic action of opioid-antagonists. Prostaglandins 1979, 18:201-208.
10. Fröde T.S., Souza G.E.P., Calixto J.B. The modulatory role played by TNF-α and IL-1β in the inflammatory responses induced by carrageenan in the mouse model of pleurisy. Cytokine 2001, 13:162-168.
11. Gilligan J.P., Lovato S.J., Erion M.D., Jeng A.Y. Modulation ofcarrageenan-induced hind paw edema by substance P. Inflammation 1994, 18:285-292.
12. Hayashida K., Takeuchi T., Harada E. Lactoferrin enhances peripheral opioid-mediated antinociception via nitric oxide in rats. European Journal of Pharmacology 2004, 484:175-181.
13. Hayashida K., Takeuchi T., Shimizu H., Ando K., Harada E. Novel function of bovine milk-derived lactoferrin on antinociception mediated by μ-opioid receptor in the rat spinal cord. Brain Research 2003, 965:239-245.
14. Hayashida K., Takeuchi T., Shimizu H., Ando K., Harada E. Lactoferrin enhances opioid-mediated analgesia via nitric oxide in the rat spinal cord. American Journal of Physiology - Regulatory, Integrative, and Comparative Physiology 2003, 285:R306-R312.
15. Hayes A.G., Sheehan M.J., Tyers T.B. Differential sensitivity of models of antinociception in the rat, mouse and guinea-pig to μ- and κ-opioid receptor agonists. British Journal of Pharmacology 1987, 91:823-832.
16. Henriques M.G., Silva P.M., Martins M.A., Flores C.A., Cunha F.Q., Assreuy-Filho J., et al. Mouse paw edema. A new model for inflammation?. Brazilian Journal of Medical and Biological Research 1987, 20:243-249.
17. Hunskaar S., Hole K. The formalin test in mice: dissociation between inflammatory and non-inflammatory pain. Pain 1987, 30:103-114.
18. Hunskaar S., Berger O.G., Hole K. Dissociation between antinociceptive and anti-inflammatory effects of acetylsalicylic acid and indomethacin in the formalin test. Pain 1986, 25:125-132.
19. Hunskaar S., Fasmer O.B., Hole K. Formalin test in mice, a useful technique for evaluating mild analgesics. Journal of Neuroscience Methods 1985, 14:69-76.
20. Korhonen H. Milk-derived bioactive peptides: from science to applications. Journal of Functional Foods 2009, 1:177-187.
21. Koster R., Anderson M., de Beer E.J. Acetic acid for analgesic screening. Federation Proceedings 1959, 18:412-421.
22. Krissansen G.W. Emerging health properties of whey proteins and their clinical implications. Journal of the American College of Nutrition 2007, 26:713S-723S.
23. Levine J.D., Taiwo Y.O. Involvement of the μ-opiate receptor in peripheral analgesia. Neuroscience 1989, 32:571-575.
24. Madureira A.R., Tavares T., Gomes A.M.P., Pintado M.E., Malcata F.X. Invited review: physiological properties of bioactive peptides obtained from whey proteins. Journal of Dairy Science 2010, 93:437-455.
25. Miyazawa K., Mantel C., Lu L., Morrison D.C., Boxmeyer H.E. Lactoferrin-lipopolysaccharide interactions: effect on lactoferrin binding to monocyte/macrophage-differentiated HL-60 cells. Journal of Immunology 1991, 146:723-729.
26. Nunes F.P.B., Sampaio S.C., Santoro M.L., Sousa-e-Silva M.C. Long-lasting anti-inflammatory properties of Crotalus durissus terrificus snake venom in mice. Toxicon 2007, 49:1090-1098.
27. Ochi T., Motoyama Y., Goto T. The analgesic effect profile of FR122047, a selective cyclooxygenase-1 inhibitor, in chemical nociceptive models. European Journal of Pharmacology 2000, 391:49-54.
28. Pedernera A., Guardia T., Guardia-Calderón C., Rotelli A., de la Rocha N., Saad J., et al. Anti-inflammatory effect of Acacia visco extracts in animal models. Inflammopharmacology 2010, 18:253-260.
29. Posadas I., Bucci M., Roviezzo F., Rossi A., Parente L., Sautebin L., et al. Carrageenan-induced mouse paw oedema is biphasic, age-weight dependent and displays differential nitric oxide cyclooxygenase-2 expression. British Journal of Pharmacology 2004, 142:331-338.
30. Rang H.P., Dale M.M., Ritter J.M. Fármacos anti-inflamatórios e imunosupressores. Farmacologia 2007, 206-207. Elsevier, Rio de Janeiro, Brazil. 6th ed. H.P. Rang, M.M. Dale (Eds.).
31. Rates S.M.K., Barros H.M.T. Modelos animais para avaliação da dor: métodos para triagem de novos analgésicos. Revista Brasileira de Ciências Farmacêuticas 1994, 75:31-34.
32. Samad T.A., Moore K.A., Sapirstein A., Billet S., Allchorne A., Poole S., et al. Interleukin-1β-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity. Nature 2001, 410:471-475.
33. Santos A.R.S., Gadotti V.M., Oliveira G.L., Tibola D., Paszuck A.P., Neto A., et al. Mechanisms involved in the antinociception caused by agmatine in mice. Neuropharmacology 2005, 48:1021-1034.
34. Schmelzer K.R., Inceoglu B., Kubala L., Kim I.-H., Jinks S.L., Eiserich J.P., et al. Enhancement of antinociception by coadministration of nonsteroidal anti-inflammatory drugs and soluble epoxide hydrolase inhibitors. Proceedings of the National Academy of Sciences of United States of America 2006, 103:13646-13651.
35. Shafiee A., Bagheri M., Shekarchi M., Abdollahi M. The antinociceptive activities of 1-(4-aryl-2-thiazolyl)-3,5-disubstituted-2 pyrazolines in mouse writhing test. Journal of Pharmaceutical Sciences 2003, 6:360-362.
36. Shibata M., Ohkubo T., Takahashi H., Inoki R. Modified formalin test: characteristic biphasic pain response. Pain 1989, 38:347-352.
37. Smith C.J., Zhang Y., Koboldt C.M., Muhammad J., Zweifel B.S., Shaffer A., et al. Pharmacological analysis of cyclooxygenase-1 in inflammation. Proceedings of the National Academy of Sciences of United States of America 1998, 95:13313-13318.
38. Spindola H., Servat L., Denny C., Rodrigues R., Eberlin M., Cabral E., et al. Antinociceptive effect of geranylgeraniol and 6α,7β-dihydroxyvouacapan-17β-oate methyl ester isolated from Pterodon pubescens Benth. BMC Pharmacology 2010, 10:1-10.
39. Suzuki R., Dickenson A. Spinal and supraspinal contributions to central sensitization in peripheral neuropathy. Neurosignals 2005, 14:175-181.
40. Takeuchi T., Hayashida K.I., Inagaki H., Kuwahara M., Tsubone H., Harada E. Opioid mediated suppressive effect of milk-derived lactoferrin ondistress induced by maternal separation in rat pups. Brain Research 2003, 979:216-224.
41. Tavares T., Amorim M., Gomes D., Pintado M.E., Pereira C.D., Malcata F.X. Manufacture of bioactive peptide-rich concentrates from whey: characterization of pilot process. Journal of Food Engineering 2012, 110:547-552.
42. Tavares T., Contreras M.M., Amorim M., Pintado M., Recio I., Malcata F.X. Novel whey-derived peptides with inhibitory effect against angiotensin-converting enzyme: invitro effect and stability to gastrointestinal enzymes. Peptides 2011, 32:1013-1019.
43. Tavares T.G., Monteiro K.M., Possenti A., Pintado M.E., Carvalho J.E., Malcata F.X. Antiulcerogenic activity of peptide concentrates obtained from hydrolysis of whey proteins by proteases from Cynara cardunculus. International Dairy Journal 2011, 21:934-939.
44. Tjolsen A., Berge O.G., Hunskaar S., Rosland J.H., Hole K. The formalin test: an evaluation of the method. Pain 1992, 51:5-17.
45. Tornos M.P., Sáenz M.T., García M.D., Fernández M.A. Antinociceptive effects of the tubercles of Anredera leptostachys. Journal of Ethnopharmacology 1999, 68:229-234.
46. Ushida Y., Shimokawa Y., Toida T., Matsui H., Takase M. Bovine α-lactalbumin stimulates mucus metabolism in gastric mucosa. Journal of Dairy Science 2007, 90:541-546.
47. Voipio H.M., Baneux P., de Segura I.A.G., Hau J., Wolfensohn S. Guidelines for the veterinary care of laboratory animals: report of the FELASA/ECLAM/ESLAV Joint Working Group on Veterinary Care. Laboratory Animals 2008, 42:1-11.
48. Wang Y., Su D.M., Wang R.H., Liu Y., Wang H. Antinociceptive effects of choline against acute and inflammatory pain. Neuroscience 2005, 132:49-56.
49. Wiertelak E.P., Furness L.E., Horan R., Martinez J., Maier S.F., Watkins L.R. Subcutaneous formalin produces centrifugal hyperalgesia at a non-injected site via NMDA-nitric oxide cascade. Brain Research 1994, 27:19-26.
50. 2 and the vascular changes of inflammation. British Journal of Pharmacology 1979, 65:517-524.
51. Winter C.A., Risley E.A., Nuss G.W. Carrageenin-induced edema in hind paw of the rat as an assay for antiinflammatory drugs. Proceedings of the Society for Experimental Biology and Medicine 1962, 111:544-547.
52. Woolfe G., Macdonald A.D. The evaluation of the analgesic action of pethidine hydrochloride (demerol). Journal of Pharmacology and Experimental Therapeutics 1944, 80:300-307.
53. 2 is mediated by the inhibition of constitutive spinal cyclooxygenase-2 (COX-2) but not COX-1. Journal of Neuroscience 2001, 21:5847-5853.
54. Yalcin A.S. Emerging therapeutic potential of whey proteins and peptides. Current Pharmaceutical Design 2006, 12:1637-1643.
55. Yamaguchi M., Matsuura M., Kobayashi K., Sasaki H., Yajima T., Kuwata T. Lactoferrin protects against development of hepatitis caused by sensitization of kupffer cells by lipopolysaccharide. Clinical and Diagnostic Laboratory Immunology 2001, 8:1234-1239.
56. 2. Biological and Pharmaceutical Bulletin 2009, 32:366-371.